Hamel Associates’s iShares iBonds Dec 2031 Term Corporate ETF IBDW Stock Holding History
Bought
Maintained
Sold
Other funds holding IBDW
ACA
CIA
CAI
VVP
SVWA
Hamel Associates's IBDW Position: Q1 2026 in Review
Hamel Associates increased its iShares iBonds Dec 2031 Term Corporate ETF (IBDW) stake by 24% in Q1 2026, buying an estimated $434K and bringing the position to 105,515 shares worth $2.21M. The position accounts for 0.63% of the portfolio, ranked #41.
Hamel Associates first reported a position in IBDW in Q4 2025 and has held it in 2 quarters since. 288 funds tracked by Wall St. Rank hold IBDW as of Q1 2026.
- Hamel Associates held 105,515 shares of iShares iBonds Dec 2031 Term Corporate ETF worth $2.21M as of Q1 2026.
- Hamel Associates bought 20,560 iShares iBonds Dec 2031 Term Corporate ETF shares in Q1 2026, an estimated $434K.
- iShares iBonds Dec 2031 Term Corporate ETF made up 0.63% of Hamel Associates's portfolio in Q1 2026, its #41 holding.
- Hamel Associates first reported a position in iShares iBonds Dec 2031 Term Corporate ETF in Q4 2025 and has held it in 2 quarters since.
- 288 funds tracked by Wall St. Rank held iShares iBonds Dec 2031 Term Corporate ETF as of Q1 2026.
Based on Hamel Associates's 13F filing for Q1 2026, filed 7 May 2026.